Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001104659-24-089588
Filing Date
2024-08-14
Accepted
2024-08-14 16:01:27
Documents
1
Period of Report
2024-06-30
Effectiveness Date
2024-08-14

Document Format Files

Seq Description Document Type Size
1 NT 10-Q tm2421678d1_nt10q.htm NT 10-Q 35517
  Complete submission text file 0001104659-24-089588.txt   36938
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 241207282
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)